Abstracts/Presentation Description
Join Dr. Cameron Snell, a leading expert in anatomical pathology, for an in-depth exploration of the transformative role predictive biomarkers are playing in advancing gastric cancer diagnosis and treatment. This session will cover:
- Learn how emerging biomarkers are helping clinicians predict treatment response, stratify patients, and personalise therapeutic strategies to improve gastric cancer outcomes.
- Discover how digital pathology tools, including AI-based quantification platforms and imaging technologies, are enhancing the accuracy and efficiency of biomarker interpretation, enabling better clinical decision-making.
- Gain insights into the real-world implementation of biomarker-driven approaches, including overcoming challenges such as inter-laboratory variability, tissue sample limitations, and clinical adoption hurdles.